Related Experiment Video
Updated: Aug 7, 2026

07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Are currently deployed artemisinins neurotoxic?
1Royal Free and University College Medical School, London, UK; Travel Clinic, Cape Town, South Africa. malaria@freesurf.ch
Toxicology Letters
|July 11, 2006
Summary
Artemisinins, used to treat malaria, may cause neurotoxicity, including hearing loss and tremors. Further review of their safety profile is recommended, particularly for pediatric use.
Area of Science:
- Pharmacology
- Neuroscience
- Toxicology
Background:
- Artemisinins are frontline antimalarial drugs.
- Emerging evidence suggests potential neurotoxic effects.
Purpose of the Study:
- To review the neurotoxic potential of artemisinins.
- To assess the safety profile of artemisinins, especially in pediatric populations.
Main Methods:
- Review of in vitro, animal, and human clinical studies.
- Analysis of reported neurotoxic effects and potential mechanisms.
Main Results:
- Consistent pattern of brainstem injuries, including auditory centers, in animals.
- Reported human neurotoxicity includes hearing loss, ataxia, and tremor.
- Oxidative stress implicated in artemisinin-induced neurotoxicity.
Conclusions:
- Artemisinin neurotoxicity may not be immediate but is irreversible once initiated.
- Current safety profiles require review, particularly for pediatric use.
- Development of non-neurotoxic artemisinins is encouraged.
Related Concept Videos
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
